Literature DB >> 8856255

Oxyphil cell function in secondary parathyroid hyperplasia.

Y Tanaka1, H Funahashi, T Imai, H Seo, Y Tominaga, H Takagi.   

Abstract

Oxyphil cell function in secondary parathyroid hyperplasia due to chronic renal failure was evaluated using in situ hybridization and heterotransplantation of parathyroid tissue. In situ hybridization and histologic analysis were performed on continuous frozen sections using 22 parathyroid tissues. A restricted area composed exclusively of oxyphil cells was observed in 10 specimens, and an area of only chief cells was found in 12 specimens. Silver grains demonstrating the existence of parathyroid hormone (PTH) mRNA were 18.8 +/- 7.8 (mean +/- SD) in oxyphil cells while those in chief cells were 17.2 +/- 7.5. PTH mRNA was abundant in both the oxyphil and chief cells. Further analysis of oxyphil cell function was assessed by the heterotransplantation of parathyroid nodules, consisting exclusively of oxyphil or chief cells, into nude mice. The function of these implants was assessed by measuring the concentration of human intact PTH which did not cross-react with mouse PTH. Serum PTH concentrations were correlated with the volume of implanted tissue. Elevations of PTH concentrations were similar in the mice transplanted with oxyphil or chief cells, indicating that both cell types had similar PTH secretory activity. The basic histologic characteristics of both cell types were not altered following transplantation. These results demonstrate that oxyphil cells in secondary parathyroid hyperplasia synthesize and secrete PTH, and that this secretion contributes to the pathophysiology of hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856255     DOI: 10.1159/000189144

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

1.  Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease.

Authors:  Yue Ding; Qiang Zou; Yiting Jin; Jian Zhou; Hongying Wang
Journal:  Int Urol Nephrol       Date:  2019-11-04       Impact factor: 2.370

2.  Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients.

Authors:  Jianping Mao; Huaizhou You; Mengjing Wang; Li Ni; Qian Zhang; Minmin Zhang; Jing Chen
Journal:  Amino Acids       Date:  2022-03-29       Impact factor: 3.520

3.  Parathyroid Cell Differentiation from Progenitor Cells and Stem Cells: Development, Molecular Mechanism, Function, and Tissue Engineering.

Authors:  Selinay Şenkal; Ayşegül Doğan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Secretion of parathyroid hormone may be coupled to insulin secretion in humans.

Authors:  Marie Reeberg Sass; Nicolai Jacob Wewer Albrechtsen; Jens Pedersen; Kristine Juul Hare; Nis Borbye-Lorenzen; Katalin Kiss; Tina Vilsbøll; Filip Krag Knop; Steen Seier Poulsen; Niklas Rye Jørgensen; Jens Juul Holst; Cathrine Ørskov; Bolette Hartmann
Journal:  Endocr Connect       Date:  2020-07       Impact factor: 3.335

5.  Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia.

Authors:  H Funahashi; Y Tanaka; T Imai; M Wada; K Tsukamura; Y Hayakawa; N Matsuura; T Kikumori; M Oiwa; Y Tominaga; H Takagi
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

6.  Differential gene expression by oxyphil and chief cells of human parathyroid glands.

Authors:  Cynthia S Ritter; Bruce H Haughey; Brent Miller; Alex J Brown
Journal:  J Clin Endocrinol Metab       Date:  2012-05-14       Impact factor: 5.958

Review 7.  The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD.

Authors:  Chien-Lin Lu; Dong-Feng Yeih; Yi-Chou Hou; Guey-Mei Jow; Zong-Yu Li; Wen-Chih Liu; Cai-Mei Zheng; Yuh-Feng Lin; Jia-Fwu Shyu; Remy Chen; Chung-Yu Huang; Kuo-Cheng Lu
Journal:  Nutrients       Date:  2018-12-03       Impact factor: 5.717

8.  A review of parathyroid mass and patients with nonspecific complaints.

Authors:  Aslıhan Dilara Demir
Journal:  J Int Med Res       Date:  2019-02-21       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.